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hnmunity to Haemophilus influenzae type b can be mediated by serum antibody 
to  the  capsular  polysaccharide (CP) 1 (1).  Immunization  of human  adults  and 
older  children  with  isolated  CP  induces antibody;  however,  immunization of 
young infants fails to induce an antibody response (2, 3). The antibody response 
is inconsistent, nonboostable, low in titer, and nonprotective in children younger 
than ~18  mo of age. Children above that age can mount a  protective antibody 
titer,  but  its  magnitude remains  less  than  the  adult's  until  ~4  y  of age.  The 
cellular  basis  of antibody  unresponsiveness  and  the  delay of high-magnitude 
responses is unknown. In an effort to convert the CP to a more thymus-dependent 
(TD) immunogen, oligosaccharides prepared from the CP (4-6) or the CP itself 
(7, 8) have been presented with protein carriers.  When the oligo conjugate was 
injected sequentially at ages  2,  4,  and  6  mo,  a  mainly IgM  primary and  IgG 
secondary anti-CP antibody response  was induced (5).  In  infants thus primed, 
titers could be further boosted by immunizing with isolated CP, even at an age 
normally unresponsive  to CP  vaccine (5).  To  elucidate the basis,  at the  B  cell 
clonal level, of the increased antibody titer induced by the conjugate, and of the 
accelerated age-acquisition of responsiveness to the isolated CP, we have ana- 
lyzed IEF patterns of serum antibody of the IgG isotype. 
Materials and Methods 
Vaccines.  The conjugate vaccine was composed of oligosaccharides 3-10  repeating 
units in length (derived by hydrolysis of the H.  influenzae  b CP),  coupled by reductive 
amination to diphtheria toxoid or the antigenically related nontoxic protein, CRM  197 
(4). The conjugates contained -4% saccharide and 96% protein, wt/wt (4, 5). The dosage 
was 25/lg protein injected s.c. Purified CP (2) was later given to some subjects (a 10-ug 
s.c. injection). The age of the vaccinees and the intervals between vaccination are noted 
below. 
Antibody Quantitation.  Serum antibody to the H.  influenzae b CP was measured in a 
Farr-type radioantigen binding assay using [ H]CP, and calibrated with standard antiserum 
SK (Office of Biologics, U.S. Food and Drug Administration) as described (9). 
This work was supported by grants AI 17217 and AI 17938 from the National Institutes of Health, 
Bethesda, M  D. 
J  Abbreviations used in this  paper:  CP, capsular  polysaccharide;  TD, thymus dependent; TI, thymus 
independent. 
262  J. ExP. MED. © The Rockefeller University  Press • 0022-1007/86/2/0262/08  $1.00 
Volume 163  February 1986  262-269 INSEL  AND  ANDERSON  263 
IEF of Serum  Antibody.  Analytical IEF was performed  in vertical  slab gels that  were 
cast and run exactly as described (10). Antibody was detected by incubating on the focused 
gel, which had been preincubated  in  18% sodium sulfate as described (8), 25 #Ci of z~I- 
labeled  CP (10 #Ci/t~g CP), prepared  by radioiodination of tyramine-coupled CP.  After 
exposure  to  the  labeled  antigen,  the  gel  was  repetitively  incubated  with  18%  sodium 
sulfate, crosslinked with  18% sodium sulfate in 0.1% glutaraldehyde, desalted, and dried 
(10).  The  dried  gels  were  exposed  to  Kodak  X-Omat  AR  film  (Eastman  Kodak  Co., 
Rochester, NY). 
Results  and  Discussion 
The  anti-CP  IgG antibody induced  by primary  immunization  with  the conju- 
gate vaccine showed limited diversity on analytical  IEF gels (Figs.  1 and 2).  The 
patterns of most subjects were easily resolved, and as few as two clonotypes were 
visible from some serum samples.  Most clonotypes had pI of 7,5-9.5.  Clonotypes 
FIGURE  1.  IEF patterns of serum antibody to the H. influenzae b capsular polysaccbaride  of 
children  of designated  ages before, and ~4 wk after primary or secondary (post  1  °; post 2 °) 
immunization  with the conjugate vaccine. Antibody titers (ug/ml) are given. A volume of 30 
ul was applied  to the gel except where noted. (1-3) Subject  1, 15-too-old: pre, 0.07; post 1  °, 
1.9; post 2 °,  4.7.  (4-6) Subject  2,  16-too-old: pre,  0.05; post  1  °,  1.1; post 2 °,  4.6.  (7-9) 
Subject 3, 30-too-old: pre, 2.2; post  1  o, 28 (20 ~l); post 2 °, 50 (10 t~l). (10-12) Subject 4, 29- 
too-old: pre, 0.13; post  1  °, 22 (20 ul); post 2 °,  180 (5 ul). (13, 14) Subject 5, 27-too-old: post 
1  °,  10 (20 ul); post 2 °, 58 (10 ul). (15, 16) Subject 6, 18-too-old: post 1  °, 1.7; post 2 °, 22. F
~
G
U
R
E
 
2
.
 
I
E
F
 
p
a
t
t
e
r
n
s
 
o
f
 
s
e
r
u
m
 
a
n
t
i
b
o
d
y
 
t
o
 
t
h
e
 
H
.
 
i
n
f
l
u
e
n
z
a
e
 
b
 
c
a
p
s
u
l
a
r
 
p
o
l
y
s
a
c
c
h
a
r
i
d
e
 
(
C
P
)
 
o
f
 
c
h
i
l
d
r
e
n
 
i
m
m
u
n
i
z
e
d
 
w
i
t
h
 
t
h
e
 
c
o
n
j
u
g
a
t
e
 
v
a
c
c
i
n
e
 
a
n
d
 
b
o
o
s
t
e
d
 
w
i
t
h
 
t
h
e
 
C
P
 
v
a
c
c
i
n
e
.
 
A
n
 
e
x
c
e
p
t
i
o
n
 
i
s
 
s
u
b
j
e
c
t
 
8
,
 
w
h
o
 
h
a
d
 
a
 
l
a
t
e
 
r
i
s
e
 
i
n
 
t
i
t
e
r
 
b
e
f
o
r
e
 
a
 
C
P
 
b
o
o
s
t
e
r
,
 
p
r
e
s
u
m
a
b
l
y
 
d
u
e
 
t
o
 
c
o
l
o
n
i
z
a
t
i
o
n
.
 
D
e
s
i
g
n
a
t
i
o
n
s
 
a
r
e
 
a
s
 
i
n
 
F
i
g
.
 
1
:
 
(
1
-
5
)
 
S
u
b
j
e
c
t
 
7
,
 
2
-
t
o
o
-
o
l
d
:
 
p
o
s
t
 
I
 
°
 
c
o
n
j
u
g
a
t
e
,
 
0
.
0
3
;
 
p
o
s
t
 
2
 
°
,
 
0
.
1
5
;
 
p
o
s
t
 
3
 
°
,
 
3
.
3
.
9
-
t
o
o
-
o
l
d
:
 
p
r
e
 
C
P
,
 
4
.
7
;
 
p
o
s
t
 
C
P
,
 
1
0
0
 
(
5
 
#
l
)
.
 
(
6
-
1
0
)
 
S
u
b
j
e
c
t
 
8
,
 
2
-
 
t
o
o
-
o
l
d
:
 
p
o
s
t
 
1
 
°
 
c
o
n
j
u
g
a
t
e
,
 
0
.
0
4
;
 
p
o
s
t
 
2
 
°
,
 
1
.
1
;
 
1
 
m
o
 
p
o
s
t
 
3
 
°
,
 
4
.
2
;
 
3
 
m
o
 
p
o
s
t
 
3
 
°
,
 
0
.
5
4
 
(
1
0
 
t
A
)
;
 
5
 
m
o
 
p
o
s
t
 
3
 
°
,
 
7
0
 
(
1
0
 
~
1
)
~
 
(
1
1
-
1
6
)
 
S
u
b
j
e
c
t
 
9
,
 
1
4
-
m
o
-
o
l
d
:
 
p
r
e
 
c
o
n
j
u
g
a
t
e
,
 
0
.
0
8
 
(
2
0
 
u
l
)
;
 
p
o
s
t
 
1
 
°
,
 
4
.
3
 
(
2
0
 
u
l
)
;
 
p
o
s
t
 
2
 
°
,
 
4
.
7
 
(
2
0
 
u
l
)
.
 
2
0
-
t
o
o
-
o
l
d
:
 
p
r
e
 
C
P
,
 
0
.
9
2
 
(
2
0
 
u
l
)
;
 
p
o
s
t
 
C
P
,
 
1
4
 
(
4
 
u
l
)
;
 
p
o
s
t
 
C
P
,
 
1
4
 
(
2
0
 
#
1
)
.
 
(
1
7
-
2
1
)
 
S
u
b
j
e
c
t
 
1
0
,
 
9
-
t
o
o
-
o
/
d
:
 
p
r
e
 
c
o
n
j
u
g
a
t
e
,
 
0
.
0
6
;
 
p
o
s
t
 
1
 
°
,
 
1
.
8
;
 
p
o
s
t
 
2
 
°
,
 
1
0
.
 
1
8
-
m
o
-
o
l
d
:
 
p
r
e
 
C
P
,
 
1
,
6
;
 
p
o
s
t
 
C
P
,
 
2
8
0
 
(
2
 
~
d
)
.
 
(
2
2
-
2
6
)
 
S
u
b
j
e
c
t
 
1
1
,
 
1
0
-
t
o
o
-
o
l
d
:
 
p
o
s
t
 
1
 
°
 
c
o
n
j
u
g
a
t
e
,
 
0
.
1
0
;
 
p
o
s
t
 
2
 
°
,
 
0
.
7
4
;
 
p
o
s
t
 
3
 
°
,
 
2
.
2
.
 
1
7
-
t
o
o
-
o
l
d
:
 
p
r
e
 
C
P
,
 
4
.
2
;
 
p
o
s
t
 
C
P
,
 
9
8
 
(
2
.
5
 
~
1
)
.
 
©
 
©
 
>
 
>
 
[
 
©
 
.
q
 
Z
 
©
 
,
z
 
©
 
>
 
*
q
 
<
 
>
 
z
 INSEL AND ANDERSON  265 
were usually not visible before immunization (Figs. 1 and 2), and were sometimes 
not visible until after secondary immunization  in the youngest children  (Fig. 2). 
The antibody expression  was no more diverse than  that  observed in  serum  of 
older  children  after  immunization  with  the  isolated  CP  (Fig.  3).  Children  of 
increasing age immunized  with the isolated  CP showed more diverse antibody 
expression (Fig.  3), but their  patterns remained  relatively restricted  in spite of 
their increasing antibody titers, similar to the response of adults (10). The adult 
response also showed a lack of correlation between the magnitude of the antibody 
titer  and  the  degree  of clonal  heterogeneity,  with  persistence  of dominant 
clonotypes for years after immunization  (10). 
The response to secondary immunization  with conjugate vaccines was accom- 
panied by increased expression predominantly of the same IgG antibody clono- 
types that had been expressed after the primary dose of vaccine (Figs.  1 and 2). 
Reimmunization  with  a  third  dose  of conjugate  vaccine  also  predominately 
increased expression of the same clonotypes expressed  after earlier  immuniza- 
tions (Fig.  2).  New clonotypes were detected only occasionally after the second 
(Fig.  1,  lane  6) or third  immunization  (Fig.  2,  lane  8);  and,  if expressed,  they 
FIGURE 3.  IEF patterns of serum antibody to  the H~  influenzae b  CP of 18-47-too-old 
children immunized with the purified CP vaccine and applied to the gel left to right in order 
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usually had lower pI than  those previously expressed.  Similar results following 
reimmunization  have been observed in 26 subjects. 
In contrast, the H. influenzae b CP and the CP of most other bacteria cannot 
prime by themselves for IgG memory responses in either man (2-4) or animals; 
in animals it is known that simultaneous activation of T  cell help is required for 
priming (I I). Presumably, the protein carrier is providing that effect. The ability 
of secondary immunization  to activate the dominant  clones previously primed, 
and the lack either of recruitment of more diverse antibody-secreting precursors 
or the lack of detectable somatic mutations in the Ig V region gene segments of 
previously primed B cells resemble the observations (12) of the permanence of 
the  IgG  clonal  antibody  patterns  established  by  primary  immunization  with 
group  A  and  A-variant  polysaccharide  after  repetitive  immunization  in  mice. 
This fixed, rather  than  expanding,  repertoire of antibody-producing cells after 
repeated conjugate immunization,  which to our knowledge has not been previ- 
ously shown  in  man,  contrasts  with  the  maturation  of the  immune  responses 
during secondary immune responses to most protein antigens and haptens (13). 
Immunization of children with isolated CP after a series of conjugate vaccines 
was capable of further increasing the antibody titer (5).  It was possible that the 
conjugate vaccine had stimulated  an  IgG memory response in  two different  B 
cell subpopulations;  one that would be responsive and one that  remained  non- 
responsive to immunization  with the CP itself. In mice, TD forms of an antigen 
can  stimulate  diverse precursors,  not all  of which  can  consistently respond  to 
thymus-independent  (TI)  forms  of the  same  epitope  (14,  15),  a  finding  that 
suggests a dual rather than linear pathway of development. Here, however, the 
isolated CP increased expression or reexpression of the same antibody clonotypes 
that had previously been induced by the conjugate vaccine, and all the clonotypes 
induced by the conjugate vaccine were restimulated  by immunization  with the 
isolated CP (Fig. 2). This result has been observed in seven of the eight subjects 
studied.  In one subject, the IEF clonotype pattern at the time of CP immuniza- 
tion, which was 3 mo after the third conjugate immunization,  differed from that 
observed  at  two  and  one-half  weeks after  conjugate  immunization.  The  CP 
vaccine did,  however, boost all  the clonotypes apparent  in the  CP preimmuni- 
zation  serum.  The  finding  that  all  the  clones  expressed  after  the  conjugate 
vaccine were restimulated  by CP suggests that,  functionally,  only one type of 
memory cell exists after multiple immunization  with a conjugate vaccine, and it 
is a  memory cell responsive to CP.  We do not know whether the precursor cell 
induced by the conjugate to respond to CP initially belonged to a potentially CP- 
responsive subset and  has  the ability to respond  to a  TD form of the  antigen 
earlier in ontogeny than  to the isolated CP, or belonged to a subset that would 
normally be unresponsive  or easily tolerized  to the  CP (11,  16,  17), and  with 
exposure to the conjugate vaccine has become CP-responsive. A precedent for 
the  former  possibility has  been  described  (16)  in  the  earlier  development,  in 
mice, of an antidextran antibody response to immunization with isomaltohexaose 
coupled to KLH than to immunization with dextran itself. With either possibility, 
our findings suggest that the developmental pathway for this antibody response 
is occurring along a single common linear pathway with a changing requirement INSEL AND ANDERSON  267 
for T  cell-dependent  activation.  Once a  TD  form of the antigen  has  induced 
memory ceils, the TI form can restimulate a response from that memory cell. 
New clonotypes were occasionally apparent (at the time of immunization  with 
CP)  that  had  not  been  detected  1  mo after  conjugate  immunization  (Fig.  2, 
subject  11), a  finding  usually associated with  an  increase  in  the antibody titer 
during the interval between immunization,  as well as with increased expression 
of the clonotypes primed by conjugate vaccine. These new clonotypes were also 
boosted by CP immunization.  New clonotypes were occasionally apparent after 
CP immunization  (Fig.  2,  subjects 9-11),  which  may represent  the product of 
new  memory  cells  induced  during  the  interval  between  conjugate  and  CP 
immunization, or which may represent induction by the CP of a different isotype 
switch of the conjugate-primed  memory ceil.  In one subject (Fig.  2, subject 8), 
the antibody titer at 3 mo after receiving conjugate vaccine, which had decreased 
from the 1 mo postimmunization titer, increased > 100-fold following presumably 
environmental  antigenic exposure 3-5 mo after conjugate immunization.  This 
marked  boost in  titer  was also accompanied by increased  expression  of all  the 
clonotypes expressed after conjugate immunization,  as well as expression of new 
clonotypes. The  finding that an increase in antibody titer after the peak post- 
conjugate vaccine antibody response was accompanied by increased  expression 
of the conjugate-primed  clonotypes suggests that  environmental  exposure to a 
TD form of the CP on a different carrier or to a TI form of the CP also has the 
ability to restimulate conjugate-primed memory cells. 
These observations differ  from  the  immunogenicity  in  animals  of some CP 
and  CP  conjugate  vaccines.  The  antibody  response  in  mice  and  rabbits  to 
immunization  with the H. influenzae b CP is poor, whether administered  either 
as a primary vaccine or as a secondary vaccine after priming with either conjugate 
vaccines or killed bacteria (2, 7, 8, and our unpublished observations). In contrast, 
immunization  of rabbits  and  mice  with  killed  pneumococci  or  TD  forms  of 
pneumococcal CP can prime for secondary responses to the isolated CP (18-21). 
However, the secondary response to the isolated CP is not produced until fairly 
long after primary immunization  (19), and is produced later than  observed for 
secondary  responses  to  TD  forms  of  the  CP  (21).  Furthermore,  secondary 
immunization  of animals with the TI form of an antigen  or a CP after priming 
with the TD form can, at times, produce exhaustive differentiation of the clones 
without proliferation and regeneration of memory (14,  18,  19).  However, there 
is no evidence that exhaustive differentiation is occurring in these human B cells, 
as the children primed with conjugate vaccine and boosted with the isolated CP 
have  had  persistent  high-magnitude  antibody  titers  for  >1  yr  after  the  CP 
immunization. 
Summary 
The diversity of the IgG antibody induced by immunization  of human infants 
and  children  with  conjugate  vaccines, composed of oligosaccharides  prepared 
from the Haemophilus influenzae b  capsular polysaccharide  (CP) and  covalently 
linked to diphtheria toxoids, was studied by analytical IEF. The antibody response 
was similar, in the degree of restriction, to that observed in the antibody response 
of older children  to  immunization  with  the  CP alone.  The  booster responses 268  OL1GOSACCHAR1DE-PROTEIN  CONJUGATE  VACCINES 
induced by  reimmunization  with  conjugate  vaccines were accompanied  by  in- 
creases predominantly in the IgG antibody clonotypes expressed after the prim- 
ing  dose of vaccine.  After a  series of conjugate immunizations,  immunization 
with isolated CP boosted the antibody titer and increased expression from all the 
clonotypes that  were  expressed after conjugate  immunization.  These  findings 
suggest that the conjugate vaccines are acting on a  limited number of human B 
cell  clones  that  are  preferentially  restimulated  after  reimmunization.  Little 
evidence of antigen-specific B cell recruitment was found. In addition, the ability 
of isolated CP immunization to restimulate the same B cell clone indicates that 
the  responding  B  cell  has  matured  and  suggests  a  linear  rather  than  a  dual 
developmental  pathway  for  the  B  cell  participating  in  this  human  antibody 
response. 
We thank Ann Kittelberger for excellent technical assistance. 
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